Rankings
▼
Calendar
ARVN Q4 2017 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$856M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
$3M
100.0% margin
Operating Income
-$5M
-206.3% margin
Net Income
-$5M
-183.8% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
+54.1%
Cash Flow
Operating Cash Flow
$28M
Free Cash Flow
$28M
Stock-Based Comp.
$82,147
Balance Sheet
Total Assets
$67M
Total Liabilities
$67M
Stockholders' Equity
$245,870
Cash & Equivalents
$31M
← FY 2017
All Quarters
Q1 2018 →